Tamoxifen Dose Adjustment on Indonesian Female ER+ Breast Cancer Patients Based on CYP2D6 Genotype and Endoxifen Levels
Clinical trial NCT04312347 · COMPLETED
Trial details
- NCT number
- NCT04312347
- Sponsor
- Nalagenetics Pte Ltd
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-06
- Primary completion
- 2021-05-01
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.